Biocorrx (BICX) to Release Quarterly Earnings on Monday

Biocorrx (OTCMKTS:BICX) is projected to issue its results after the market closes on Monday, May 11th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $0.22 million for the quarter.

Biocorrx (OTCMKTS:BICX) last announced its quarterly earnings data on Tuesday, March 31st. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.11. The business had revenue of ($0.15) million during the quarter, compared to analyst estimates of $0.22 million.

Biocorrx Stock Down 39.2%

OTCMKTS BICX traded down $0.16 during trading hours on Monday, hitting $0.24. The company’s stock had a trading volume of 1,900 shares, compared to its average volume of 7,789. The stock has a fifty day moving average of $0.37 and a 200 day moving average of $0.36. Biocorrx has a twelve month low of $0.20 and a twelve month high of $0.50. The firm has a market capitalization of $7.05 million, a P/E ratio of -1.28 and a beta of 0.17.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.